Tempest Therapeutics (TPST)
(Real Time Quote from BATS)
$7.45 USD
-0.04 (-0.53%)
Updated Aug 4, 2025 02:58 PM ET
3-Hold of 5 3
F Value C Growth B Momentum D VGM
Fundamental Charts
About Market Cap
As of the previous market close, Tempest Therapeutics, Inc. has a market cap of $27.58M, which represents its share price of $7.49 multiplied by its outstanding shares number of 3.68M. As a small-cap company, TPST's shareholders are generally exposed to more risk than shareholders of mid and large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
TPST 7.45 -0.04(-0.53%)
Will TPST be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for TPST based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for TPST
TPST Stock Up on EMA's Orphan Drug Tag for Liver Cancer Therapy
TPST to Evaluate Strategic Options for Pipeline Studies, Stock Up
TPST: What are Zacks experts saying now?
Zacks Private Portfolio Services
Other News for TPST
Tempest Therapeutics receives NMPA clearance to proceed with amezalpat trial
Tempest Therapeutics Secures $4.1M in Direct Offering
Tempest Therapeutics (TPST) Announces New Stock Purchase Agreement | TPST Stock News
Tempest announces $4.6 million registered direct offering of common stock; shares decline over 13%
Tempest prices 739,000 shares at $6.25 in registered direct offering